RxDoctor Payments Data

Jacob Albert, MD

Family Medicine · Palm Harbor, FLNPI 1265929319

Payments from drug & device makers

$14,680in general payments, 2019–2025

Across 46 payments — averaging $319.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$10K
  • Smith+Nephew$4K
  • Amgen$140
  • BD$130
  • AbbVie$92
  • GSK$70
  • plus $481 from 18 others

What the payments were for

  • Grants$10,00068%
  • Food & beverage$1,0137%
  • Education$3,66725%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,680 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$86,007
Medicare patients
270
Services billed
1,273

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$75,797
JardianceEmpagliflozin64$50,296
XareltoRivaroxaban33$26,543
MounjaroTirzepatide16$16,901
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$16,729
EliquisApixaban18$14,732
MyrbetriqMirabegron27$13,207
JanuviaSitagliptin Phosphate11$10,652
Tresiba Flextouch U-100Insulin Degludec14$2,826
Rosuvastatin Calcium210$2,716
Metformin Hcl165$1,962
Atorvastatin Calcium270$1,936
Levothyroxine Sodium226$1,910
Omeprazole118$1,836
Valsartan21$1,597

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$17$75,79760 claims
Boehringer IngelheimJardiance$18$50,29664 claims
Lilly USA, LLCMounjaro$25$16,90116 claims
GSKTrelegy Ellipta$70$16,72920 claims
PfizerEliquis$54$14,73218 claims
MerckJanuvia$50$10,65211 claims
AbbVieSynthroid$92$70426 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Palm Harbor

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →